Editorial: Quality of Life in Breast Cancer Patients and Survivors

Marco Invernizzi^{1

2}, Jisun Kim³, Nicola Fusco^{4

5}

Affiliations

¹ Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
² Physical and Rehabilitative Medicine, University Hospital "Maggiore della Carità", Novara, Italy.
³ Asan Medical Centre, Department of Surgery, College of Medicine, Ulsan University, Seoul, South Korea.
⁴ Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
⁵ Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Editorial

Marco Invernizzi et al. Front Oncol. 2020.

. 2020 Nov 18:10:620574.

doi: 10.3389/fonc.2020.620574. eCollection 2020.

Marco Invernizzi^{1

2}, Jisun Kim³, Nicola Fusco^{4

5}

¹ Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
² Physical and Rehabilitative Medicine, University Hospital "Maggiore della Carità", Novara, Italy.
³ Asan Medical Centre, Department of Surgery, College of Medicine, Ulsan University, Seoul, South Korea.
⁴ Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
⁵ Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

No abstract available

Keywords: biomarkers; breast cancer; multidisciplinary management; quality of life; survivorship.

Comment on

An Editorial on the Research Topic Quality of Life in Breast Cancer Patients and Survivors

1. Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health (2020) 8(8):e1027–37. 10.1016/s2214-109x(20)30215-1 - DOI - PubMed
1. Moye J, Langdon M, Jones JM, Haggstrom D, Naik AD. Managing Health Care After Cancer Treatment: A Wellness Plan. Federal Practitioner Health Care Professionals VA DoD PHS (2014) 31(Suppl 3):27S–32S. - PMC - PubMed
1. Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy. J Natl Cancer Institute (2019) 111(11):1120–30. 10.1093/jnci/djz089 - DOI - PMC - PubMed
1. Grizzi G, Ghidini M, Botticelli A, Tomasello G, Ghidini A, Grossi F, et al. Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options. Cancer Manag Res Volume (2020) 12:675–86. 10.2147/cmar.S202965 - DOI - PMC - PubMed
1. Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg (2018) 7(4):379–403. 10.21037/gs.2017.11.04 - DOI - PMC - PubMed